These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2687422)

  • 1. Discovery, development, and some uses of vasopressin and oxytocin antagonists.
    Manning M; Sawyer WH
    J Lab Clin Med; 1989 Dec; 114(6):617-32. PubMed ID: 2687422
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of action of vasopressin and vasopressin antagonists.
    Jard S
    Kidney Int Suppl; 1988 Oct; 26():S38-42. PubMed ID: 2974096
    [No Abstract]   [Full Text] [Related]  

  • 3. Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor.
    Chan WY; Hruby VJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):597-602. PubMed ID: 2969979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antagonists of vasopressin in studies of its physiological functions.
    Sawyer WH; Manning M
    Fed Proc; 1985 Jan; 44(1 Pt 1):78-80. PubMed ID: 2981734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of vasopressin antagonists in human diseases.
    Thibonnier M
    Kidney Int Suppl; 1988 Oct; 26():S48-51. PubMed ID: 2974097
    [No Abstract]   [Full Text] [Related]  

  • 6. The development of potent and specific vasopressin antagonists.
    Sawyer WH; Manning M
    Kidney Int Suppl; 1988 Oct; 26():S34-7. PubMed ID: 3059031
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxytocin and vasopressin in the gonads.
    Wathes DC
    Oxf Rev Reprod Biol; 1989; 11():225-83. PubMed ID: 2697830
    [No Abstract]   [Full Text] [Related]  

  • 8. The paraventricular nucleus and cardiovascular regulation: role of spinal vasopressinergic mechanisms.
    Porter JP; Brody MJ
    J Hypertens Suppl; 1986 Oct; 4(3):S181-4. PubMed ID: 2946826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin antagonists: present and future.
    Hofbauer KG; Mah SC
    Kidney Int Suppl; 1987 Aug; 21():S76-82. PubMed ID: 3306108
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxytocin and vasopressin stimulate anion secretion by human and porcine vas deferens epithelia.
    Hagedorn TM; Carlin RW; Schultz BD
    Biol Reprod; 2007 Sep; 77(3):416-24. PubMed ID: 17442854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and clinical perspectives of vasopressin antagonists.
    László FA; László F; De Wied D
    Pharmacol Rev; 1991 Mar; 43(1):73-108. PubMed ID: 1852013
    [No Abstract]   [Full Text] [Related]  

  • 12. The distribution of enzymes destroying oxytocin and vasopressin in human placentae.
    HOOPER KC; JESSUP DC
    J Physiol; 1959 Jun; 146(3):539-49. PubMed ID: 13665676
    [No Abstract]   [Full Text] [Related]  

  • 13. No requirements of cyclic conformation of antagonists in binding to vasopressin receptors.
    Manning M; Przybylski JP; Olma A; Klis WA; Kruszynski M; Wo NC; Pelton GH; Sawyer WH
    Nature; 1987 Oct 29-Nov 4; 329(6142):839-40. PubMed ID: 2959865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Wied and colleagues IV: research into mechanisms of action by which vasopressin and oxytocin influence memory processing.
    McEwen BB
    Adv Pharmacol; 2004; 50():177-225, 655-708. PubMed ID: 15350261
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxytocin causes endothelium-dependent relaxations of canine basilar arteries by activating V1-vasopressinergic receptors.
    Katusic ZS; Shepherd JT; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Jan; 236(1):166-70. PubMed ID: 3001282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin, vasopressin, and social recognition in mammals.
    Bielsky IF; Young LJ
    Peptides; 2004 Sep; 25(9):1565-74. PubMed ID: 15374658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central oxytocin antagonism decreases female reproductive behavior.
    Witt DM; Insel TR
    Ann N Y Acad Sci; 1992 Jun; 652():445-7. PubMed ID: 1320836
    [No Abstract]   [Full Text] [Related]  

  • 19. Expansion of vasopressin/oxytocin memory research II: brain structures and transmitter systems involved in the influence of vasopressin and oxytocin on memory processing.
    McEwen BB
    Adv Pharmacol; 2004; 50():389-420, 655-708. PubMed ID: 15350266
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala.
    Huber D; Veinante P; Stoop R
    Science; 2005 Apr; 308(5719):245-8. PubMed ID: 15821089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.